IASLC 2015 Annual Report
Among the major highlights from 2015 are the completion of two of IASLC’s global initiatives: The 8th Edition of the Tumor, Node and Metastasis (TNM) Classification of Lung Cancer, this time including the thymus and esophagus, and the 2015 WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (Fourth edition). Congratulations to all those involved in these very significant projects. Additionally in 2015, we smoothly transitioned our journal, Journal of Thoracic Oncology, to a new publisher, Elsevier. The first issue published by Elsevier debuted in January 2016.
Never in our history has the IASLC enjoyed the outreach we had in 2015; our accomplishments vaulted our membership to a record high of more than 5,000 members in more than 100 countries. In addition to our successful webinars in both the U.S. and Europe, the IASLC School of Thoracic Oncology arranged several Live Learning programs, designed for fellows and junior faculty members in particular. We enjoyed incredible success in all our 2015 meetings, notably the World Conference on Lung Cancer (WCLC) in Denver which gathered over 6,000 participants from nearly 100 countries and showcased many new advances in lung cancer science. We also launched more focused, smaller meetings, such as the Small Cell Lung Cancer meeting and the consensus meeting on Management of EGFR Mutant NSCLC.
However, lung cancer remains to be a significant health problem and a challenge to conquer. IASLC is committed to the challenges to ensure that optimal care of patients with thoracic malignancies is ensured all over the world. Members, volunteers, and staff of the IASLC have worked diligently to accomplish the goals of the strategic plan and fulfill the mission of the society. Within the report one can find details on the organizational structure, membership, fellowships, education activities, publications, awards, meetings, the strategic plan, advocacy partners and sponsors.